SOURCE: Informa

Informa

November 10, 2015 13:35 ET

Top Biopharma Projects to Watch

Biopharma Leaders to Present at Therapeutic Area Partnerships Conference, Boston, November 18-20

BOSTON, MA--(Marketwired - November 10, 2015) - The 10th Annual Therapeutic Area Partnerships meeting, hosted by IIR USA, an Informa company, will bring together more than 160 biopharma leaders in Boston on November 18-20, 2015 to assess the most promising drug programs for partnering.

Top projects will be presented across today's "hottest" therapeutic areas including cardiovascular/metabolic diseases, neuroscience, anti-inflammatory/autoimmune diseases, oncology/immune-oncology, infectious and emerging diseases, advanced therapies; cell, gene & stem therapies, orphan and rare diseases and academic technology transfer.

Each project has been hand-selected by an elite panel to ensure a high-quality slate of presenters. Details on the top projects to watch under each therapeutic area can be found at: http://www.iirusa.com/therapeuticareapartnership/agenda.xml

Attendees have the opportunity to hear from and meet some of the industry's most talented biotechnology entrepreneurs and pharmaceutical leaders. Casual gatherings and one-on-one partnering meetings bring together business development decision makers from large pharmaceutical firms and executive leadership from innovative biotechnology firms to make this one of the industry's most productive events.

To register, contact Howie Choi at hchoi@ibcusa.com or register at the Therapeutic Area Partnerships website at https://www.iirusa.com/therapeuticareapartnership/registration.xml.

About IIR USA

IIR USA conceives and executes nearly 200 proprietary events annually supporting a portfolio of major industries, professions and fields of business interest. IIR USA has also developed an extensive and constantly evolving collection of supplemental information services and networking resources, including: webinars; online communities and social media touch points; executive briefings and white papers; thought leader interviews; and much more.

Contact Information